CSPAN2 Key Capitol Hill Hearings December 17, 2014
Probably get an answer of efficacy more quickly. Once you get the efficacy you we will distribute that vaccine to everybody and anybody who might benefit. Ultimately if ultimately if it works everyone we will get. That is the framework. Then we look at the advantages and disadvantages if you are distributing a vaccine before you no it works for the advantages if it does work you get it to people quickly. The disadvantage is you may not ever prove that it does work. The inevitable next outbreak we wont no if we have a vaccine that works. The issue with the randomized controlled placebo trial as...
Source: archive.org
